Yitzhak Peterburg
Director/Board Member at Regenera Pharma Ltd.
Profile
Yitzhak Peterburg is a businessperson who has been at the helm of 6 different companies.
Dr. Peterburg is on the board of Regenera Pharma Ltd.
(former Chairman).
In the past Dr. Peterburg held the position of Director at Teva Pharmaceutical Industries Ltd., Chairman of EndyMed Ltd., Chief Executive Officer for Soroka University Medical Center, Chief Executive Officer at Clalit Health Services Group, President & Chief Executive Officer at Cellcom Israel Ltd.
and Professor at Ben-Gurion University of the Negev.
He received a graduate degree from London School of Economics & Political Science, a doctorate from The Hebrew University Hadassah Medical School, a doctorate from Joseph L.
Mailman School of Public Health and a doctorate from Columbia University.
Yitzhak Peterburg active positions
Companies | Position | Start |
---|---|---|
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Director/Board Member | - |
Former positions of Yitzhak Peterburg
Companies | Position | End |
---|---|---|
Ben-Gurion University of the Negev | Corporate Officer/Principal | 2010-01-01 |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Director/Board Member | 2010-06-30 |
ENDYMED LTD | Chairman | 2009-12-31 |
CELLCOM ISRAEL LTD. | President | 2004-12-31 |
Clalit Health Services
Clalit Health Services Hospital/Nursing ManagementHealth Services Clalit Health Services Group provides healthcare services. The firm provides general and specialized hospitals with emergency rooms, outpatient departments, day care centers, clinical pathology laboratories, and imaging departments, which include X-ray, ultrasound, CT, and MRI facilities. The company was founded in 1911 and is headquartered in Tel Aviv, Israel. | President | 2001-12-31 |
Training of Yitzhak Peterburg
The Trustees of Columbia University in The City of New York | Doctorate Degree |
London School of Economics & Political Science | Graduate Degree |
Joseph L. Mailman School of Public Health | Doctorate Degree |
The Hebrew University Hadassah Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
ROSETTA GENOMICS LTD. | Health Technology |
CELLCOM ISRAEL LTD. | Communications |
ENDYMED LTD | Health Technology |
Private companies | 4 |
---|---|
Clalit Health Services
Clalit Health Services Hospital/Nursing ManagementHealth Services Clalit Health Services Group provides healthcare services. The firm provides general and specialized hospitals with emergency rooms, outpatient departments, day care centers, clinical pathology laboratories, and imaging departments, which include X-ray, ultrasound, CT, and MRI facilities. The company was founded in 1911 and is headquartered in Tel Aviv, Israel. | Health Services |
CritiSense Ltd.
CritiSense Ltd. Medical SpecialtiesHealth Technology CritiSense Ltd. develops technology for real-time monitoring of the metabolic state of the patient. Its patient monitoring system provides real-time continuous information via four physiological parameters sensed at the tissue level reflecting the patient’s systemic metabolic state. The company was founded by Avraham Mayevsky in 2004 and is headquartered in Giv'at Shmuel, Israel. | Health Technology |
Soroka University Medical Center
Soroka University Medical Center Hospital/Nursing ManagementHealth Services Soroka University Medical Center provides medical services. The private company is based in Beer Sheva, Israel. | Health Services |
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Health Technology |